Translating non-clinical proof-of-concept data into paediatric development decisions: the case of HER2-targeting antibody-drug conjugates. // EJC Paediatric Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2772610X26000759?dgcid=rss_sd_all
Translating non-clinical proof-of-concept data into paediatric development decisions: the case of HER2-targeting antibody-drug conjugates. EJC Paediatric Oncology. https://www.sciencedirect.com/science/article/pii/S2772610X26000759?dgcid=rss_sd_all
“Translating non-clinical proof-of-concept data into paediatric development decisions: the case of HER2-targeting antibody-drug conjugates.” EJC Paediatric Oncology.
@article{article43692,
title = {Translating non-clinical proof-of-concept data into paediatric development decisions: the case of HER2-targeting antibody-drug conjugates},
journal = {EJC Paediatric Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2772610X26000759?dgcid=rss_sd_all}
}